Dental News - Osteogenics secures North American distribution of Resorba dental sutures

Search Dental Tribune

Osteogenics secures North American distribution of Resorba dental sutures

Resorba combines unique materials with specialty dental needles to create products better suited for dental surgery. (Photo: Osteogenics Biomedical)
Dental Tribune USA

Dental Tribune USA

Wed. 6 July 2016

save

LUBBOCK, Texas, USA: Osteogenics Biomedical, a leader in the development of innovative dental bone grafting products, has announced the acquisition of exclusive North American distribution rights for the premium German dental suture brand Resorba. While most sutures in dentistry are simply repositioned from medicine, Resorba, a major suture manufacturer in Germany since 1931, created a division exclusively for dentistry.

Resorba combines unique materials with specialty dental needles to create products better suited for dental surgery.

Among their unique product offering is their best-selling dental suture, Glycolon, an absorbable suture with a monofilament construction comprised of polyglycolic acid (PGA) and polycaprolactone (PCL). The monofilament structure provides excellent handling properties, does not wick bacteria, and allows for atraumatic passage through tissue. Glycolon maintains 50 percent of its tensile strength for 11 to 13 days.

Resorba dental suture needles are manufactured from premium tempered 300-series stainless steel. Select configurations are also available with a black needle that provides increased contrast in the mouth for enhanced visualization.

“Following the success of our own Cytoplast PTFE suture line, expansion of our suture portfolio was a long-term goal,” said Osteogenics President Shane Shuttlesworth. “Resorba’s focus on unique, premium products designed for dentistry fits perfectly within our product portfolio philosophy.”

More information on the complete line of Resorba dental sutures is available online, at osteogenics.com/resorbasutures, or by calling a customer service specialist at (888) 796-1923.

(Source: Osteogenics Biomedical)
 

To post a reply please login or register
advertisement
advertisement